Xarelto is made by Bayer and Johnson & Johnson. As a result of the drug makers’ failure to adequately warn about the risks associated with Xarelto, financial compensation may be available through an Xarelto lawsuit for individuals who have experienced:
- Internal Bleeding or Gastrointestinal Bleeding
- Brain Hemorrhage
- Intra-Cranial Bleed
- Intra-Cerebral Bleed
- Hemorrhagic Stroke
- Wrongful Death From Bleeding Problems
The Dr Shezad Malik Law Firm is currently investigating and accepting Xarelto uncontrollable bleeding injury cases nationwide, including California, Florida, Illinois, New York and Texas.
We are evaluating Xarelto bleeding side effect cases including uncontrollable gastrointestinal bleeding (stomach, colon, rectum), brain bleeding (intracranial bleeding, intracerebral bleeding, sub-dural hematoma), uncontrollable bleeding from minor cuts/lacerations, slip and falls, minor trauma, bleeding episodes requiring hospitalizations, blood transfusions and death.
If you or somebody you know has been injured or died as a result of Xarelto bleeding, you should contact the Xarelto Injury Team attorneys at the Dr Malik Law Firm immediately for a free case consultation. Please use the contact form to contact us or call toll free 24 hours a day at (888) 210-9693 ext 2.Xarelto 2016 Lawsuit Update
An Arizonan woman, Margaret Garvy, recently filed a product liability and personal injury lawsuit alleging that side effects of Xarelto caused her to suffer a life threatening hemorrhagic pericardial effusion.
Hemorrhagic pericardial effusion, is a serious medical condition where the sac around the heart is filled with blood, preventing the normal contractions of the heart and if left untreated can be deadly.
Garvy’s lawsuit is the latest in several thousand Xarelto uncontrollable bleeding cases filed against Bayer and Johnson & Johnson over complications linked to their controversial new anticoagulant or blood thinner medication. Garvy filed her case in the U.S. District Court of the Eastern District of Louisiana.Louisiana Xarelto Multidistrict Litigation
All Xarelto lawsuits filed in U.S. District Courts nationwide have been consolidated in the Eastern District of Louisiana as part of a federal MDL, or multidistrict litigation (MDL) since December 2014.
The MDL litigation is centralized before U.S. District Judge Eldon Fallon for coordinated discovery and pretrial proceedings.
According to the latest court information, there are more than 4,500 Xarelto injury cases on file.Plaintiff Claims Life Threatening Injury
According to Garvy, she took the anticoagulant Xarelto for less than two weeks in May 2014, and she was diagnosed with hemorrhagic pericardial effusion, pericardial tamponade and pleural effusion.
Garvy claims that the bleeding around the heart and lungs was from her Xarelto use and the lack of an effective reversal antidote to stop the drug’s anticoagulant or blood thinning effects.
Garvy alleges that Bayer and Johnson & Johnson’s Janssen Pharmaceuticals subsidiary knew or should have known about the hemorrhage risks with Xarelto, but withheld information from patients and the doctors about the fact that users may experience uncontrollable bleeding.Xarelto Linked to Hemorrhage Risks
Xarelto was approved in 2011 as a replacement medication for Coumadin (warfarin), which has been the gold standard anticoagulant treatment for the past 60 years.
Xarelto was approved for the treatment of chronic atrial fibrillation, which is a common heart rhythm problem and can lead to strokes if there is no blood thinners used.
Xarelto is a new-generation of blood thinners, which have been touted as easier to use than warfarin, because the manufacturers claim that there is no need to measure blood thinning levels.
But, a large number of adverse event reports began to be filed after Xarelto was released, usually involving uncontrollable bleeding that doctors were unable to stop.Blood Thinners Bleeding Risks
All blood thinners carry a risk of bleeding injury, and the side effects of warfarin can be quickly reversed with Vitamin K if bleeding occurs.
Unfortunately there is no Xarelto reversal agent and plaintiffs have alleged that the drug manufacturers failed to adequately warn doctors about the lack of an antidote.Xarelto Bellwether Trials
As is common in the management of defective drug litigation, Judge Fallon has established a “bellwether” program, where a small group of claims are being prepared for early trial dates.
The Xarelto bellwether trials are scheduled to go in February 2017 and May 2017.Pradaxa Uncontrollable Bleeding and Death Lawsuits
Pradaxa is a similar newer generation blood thinner made by Boehringer Ingelheim based in Germany.
This Xarelto litigation involves similar uncontrollable bleeding claims to those in thousands of Pradaxa lawsuits. The Pradaxa maker ultimately agreed to pay $650 million in Pradaxa settlements in 2014, with an average of about $150,000 per claim.